Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_2
2
40%
Ph phase_1
3
60%

Phase Distribution

3

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (60.0%)
Phase 22 (40.0%)

Trials by Status

completed240%
recruiting120%
terminated120%
unknown120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_2

A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）

NCT05979051
completedphase_2

A Study to Evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients With Eosinophil Phenotype

NCT05522439
unknownphase_1

A Trial of SHR-1703 in Asthma

NCT05042401
completedphase_1

A Trial of SHR-1703 in Healthy Adults

NCT04480762
terminatedphase_1

A Trial of SHR-1703 in Healthy Subjects

NCT04855591

Clinical Trials (5)

Showing 5 of 5 trials
NCT05979051Phase 2

A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）

Recruiting
NCT05522439Phase 2

A Study to Evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients With Eosinophil Phenotype

Completed
NCT05042401Phase 1

A Trial of SHR-1703 in Asthma

Unknown
NCT04480762Phase 1

A Trial of SHR-1703 in Healthy Adults

Completed
NCT04855591Phase 1

A Trial of SHR-1703 in Healthy Subjects

Terminated

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5